Filter
2506
Filtered Results: 2506
Text search:
drug
trial
Featured
Recommendations
231
New Publications
500
Language
Document type
No document type
1498
Guidelines
387
Studies & Reports
376
Manuals
100
Strategic & Response Plan
52
Fact sheets
40
Training Material
22
Situation Updates
13
Infographics
8
Resource Platforms
6
Brochures
3
App
1
Countries / Regions
India
145
Global
87
South Africa
63
Western and Central Europe
55
Kenya
43
Nigeria
39
Ethiopia
38
Africa
37
Uganda
36
Eastern Europe
29
Liberia
29
Zambia
28
Malawi
27
Tanzania
27
Nepal
26
Sierra Leone
26
Russia
26
Ukraine
25
Ghana
21
Zimbabwe
20
Latin America and the Carribbean
20
Rwanda
19
Asia
18
Philippines
17
Bangladesh
17
Myanmar / Burma
16
South–East Asia Region
15
Brazil
14
East and Southern Africa
13
Namibia
13
Colombia
11
Lesotho
11
Mozambique
11
Cambodia
11
West and Central Africa
11
Germany
10
USA
9
Middle East and North Africa
9
South Sudan
9
Indonesia
9
Congo, Democratic Republic of
7
Botswana
7
Eswatini/ Swaziland
7
Tajikistan
6
Thailand
6
Syria
6
Cameroon
5
Albania
5
Senegal
5
Guinea
5
Eastern Europe and Central Asia
5
Laos
4
Burkina Faso
4
Venezuela
4
Argentina
4
Vietnam
4
Papua New Guinea
4
Sudan
4
Georgia
4
China
3
Haiti
3
Paraguay
3
Spain
3
Lebanon
3
Yemen
3
Central African Republic
3
Angola
3
Pakistan
3
North Macedonia
2
Mexico
2
Benin
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Jordan
2
Jamaica
2
United Kingdom
2
Portugal
2
Belarus
2
Southern Africa
2
Bolivia
2
Sri Lanka
2
Poland
2
Iraq
2
Turkey
1
Gambia
1
Kazakhstan
1
Singapore
1
Peru
1
Qatar
1
Bulgaria
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Norway
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Mali
1
Bhutan
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
685
Clinical Guidelines
336
Public Health
138
Women & Child Health
100
Pharmacy & Technologies
29
Key Resources
24
Capacity Building
19
Toolboxes
HIV
344
Mental Health
339
TB
298
COVID-19
162
NTDs
116
AMR
89
NCDs
77
Pharmacy
72
Ebola
57
Rapid Response
34
Caregiver
30
Refugee
28
Planetary Health
25
Disability
24
Global Health Education
16
Conflict
14
Health Financing Toolbox
12
Polio
9
Social Ethics
7
Specific Hazards
5
Natural Hazards
5
Cholera
5
Zika
3
Health Financing
1
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
International Journal of Drug Policy 24 (2013) e91-98
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
The purpose of this document is to stop to irrational use/ over prescription of this reserve/
experimental/ emergency use authorisation drug Remdesivir. For this reason, Joint
Monitoring Group under Chairmanship of DGHS took into consideration findings of the
followi...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
Q1: Are brief psychosocial interventions for people using cannabis or psychostimulants effective in reducing drug use, dependence and harm from drug use?
Expert Consensus Validation 2018.
This innovative approach aimed at improving and facilitating the screening, prescribing and monitoring of drug therapy for older patients, is currently being further developed in the area of Clinical Pharmacology at the University of Heidelberg in Mannheim. This ap...
Africa Centers for Disease Control and Prevention (Africa CDC) is aware of the media releases of the preliminary results of a large randomized clinical trial conducted in the United Kingdom, which included dexamethasone, a corticosteroid, as one of the drugs used for the treatment of COVID-19 patien...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
